Dissolution Technologies

Papers
(The median citation count of Dissolution Technologies is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Study of Drug Release Kinetics of Rosuvastatin Calcium Immediate-Release Tablets Marketed in Saudi Arabia5
In Vitro Biopharmaceutical Equivalence of Carbamazepine Sodium Tablets Available in Lima, Peru4
Update on Gastrointestinal Biorelevant Media and Physiologically Relevant Dissolution Conditions4
Testing the In-Vitro Product Performance of Nanomaterial-Based Drug Products: View of the USP Expert Panel4
Development of In Vivo Predictive pH-Gradient Biphasic Dissolution Test for Weakly Basic Drugs: Optimization by Orthogonal Design3
Comparative Evaluation of In Vitro Drug Release Methods Employed for Nanoparticle Drug Release Studies3
Comparative Dissolution of Budesonide from Four Commercially Available Products for Oral Administration: Implications for Interchangeablity2
Predictive Dissolution Models for Real-Time Release Testing: Development and Implementation - Workshop Summary Report2
In Vitro Biopharmaceutical Equivalence of 5-mg Glibenclamide Tabletsin Simulated Intestinal Fluid Without Enzymes2
Stimuli to the Revision Process: The Case for Apex Vessels2
In Vitro Solubility and Release Profile Correlation with pKa Value of Efavirenz Polymorphs2
A Data Set to Verify Volume and Sample Removal Correction Calculations for Dissolution Testing2
Disintegration and Rupture Testing of Omega-3 Soft Capsules2
Evaluation of NanoDis as an Automated Sampling Technology for In Vitro Release Testing of Nanomedicines2
Dissolution Best Practices and International Harmonization - AAPS Workshop Report1
Summary Report on Workshop on In Vitro Release Test (IVRT) and In Vitro Permeation Test (IVPT) Methods1
Conventional Surfactants and a Model Based on Molecular Descriptors as Alternatives to the Drug Solubility in Fasted State Simulated Intestinal Fluid1
Comparison of Generic Furosemide Products by In Vitro Release Studies using USP Apparatus 2 and 41
Quality Assessment of Brands of Prednisolone (5 Mg) Tablets Marketed in Abuja Metropolis of Nigeria1
Quality Attributes and In Vitro Bioequivalence of Amlodipine (5 mg) Tablets in Ica, Peru1
Role of Surfactants on Dissolution Behavior of Tamoxifen1
Predicting Dissolution of Entecavir Using the Noyes Whitney Equation1
Development of In Vitro Dissolution Test Method for Bilastine and Montelukast Fixed-Dose Combination Tablets1
Dissolution Method Development for Regulatory Approval: A Comprehensive Review and Case Study1
The Combination of Liqui-Mass System and Pelletization to Improve Pharmaceutical Properties of Hydrochlorothiazide1
In-Vitro Product Performance of Parenteral Drug Products: View of the USP Expert Panel1
Questions and Answers February 20211
Biowaiver Study of Selected Solid Oral Prednisolone Products Available in Sri Lanka: Recommendations for Comparator Product Used in Biowaiver Testing1
Highlights from the 2020 AAPS 360 Annual Meeting1
In-Vitro Product Performance of Parenteral Drug Products: View of the USP Expert Panel1
Simulated Lymphatic Fluid for In-Vitro Assessment in Pharmaceutical Development1
Effect of Mannitol Particle Size on Melatonin Dissolution and Tablet Properties using a Quality by Design Framework1
Performance Tests – Update on USP Activities1
Questions and Answers August 20230
A Novel Application of an Effervescent Agent in Naproxen Liqui-Pellets for Enhanced Drug Release0
Influence of Storage Conditions on the Pantoprazole Dissolution Profile for Gastro-Resistant Tablet Formulations0
Dissolution Profile of Calcium Supplements in Brazil: A Critical Analysis and Formulation Proposal0
Comparison of Release Rates Derived from Cutaneous Versus Film-Forming Solution Containing Terbinafine: Approach Towards Qualification and Validation of In Vitro Parameters0
Comparative Dissolution Study of Atorvastatin Calcium Tabletsin Indonesia0
Highlights From the 2021 AAPS 360 Annual Meeting0
Report on the Virtual Workshop: A Quest for Biowaiver, Including Next Generation Dissolution Characterization and Modeling0
Impact of Solvent Selection and Absorptivity on Dissolution Testing of Acetylsalicylic Acid Enteric-Coated Tablets0
Highlights from 2022 AAPS 360-In Vitro Release and Dissolution Testing Community Annual Meeting0
Questions and Answers November 20230
A BCS-Based Biowaiver Approach Using Biphasic Dissolution Test0
Assessment of Drug Release Kinetics and Quality of Naproxen Generic Tablets in Bangladesh0
Evaluation of Different Methods for Dissolution Profile Similarity Comparison of Montelukast Tablets in Türkiye0
Contribution of Multivariate Analysis to the In Vitro Dissolution Profile for Testing Clopidogrel Drugs Similarity0
Virtual Workshop Report: Approaches, Regulatory Challenges, and Advances in Bioequivalence, Dissolution Testing, and Biowaivers: Manila, Philippines, February 22-24, 20230
Physicochemical Quality and In Vitro Bioequivalence of Amoxicillin Capsules Marketed in Burkina Faso, Africa0
An In Vitro Model for Release of Acetaminophen When an Overdose is Ingested Orally0
Comparative Analysis of Commercially Available Acetaminophen Tablets in Saudi Arabia0
Using a Laser Monitoring Technique for Dissolution and Thermodynamic Study of Celecoxib in 2-Propanol and Propylene Glycol Mixtures0
In Vitro Performance Tests for Continuous Manufacturing: The Impact on the Current Compendial Framework from the Viewpoint of the USP New Advancements in Product Performance Testing Expert Panel0
Book Review: “In Vitro Drug Release Testing of Special Dosage Forms,” Advances in Pharmaceutical Technology Series, Edited by Fotaki and Klein0
Formulation and Evaluation of Bisoprolol Hemifumarate Emulgel for Transdermal Drug Delivery0
Biorelevant Dissolution of Dipyridamole and Piroxicam Using an Automated UV/Vis Spectrophotometric and Potentiometric Dissolution Testing Platform0
Investigating the Influence of HPMC K4M and Eudragit L 100-55 on Guanfacine-Loaded Extended-Release Tablets0
Influence of Storage Conditions on Pharmaceutical Equivalence and Similarity of Hydrochlorothiazide Tablets in Argentina0
Comparison of Efavirenz Release in Biorelevant Dissolution Media Using Manual Sampling and In Situ UV Fiber Optic System0
Questions and Answers May 20210
Questions and Answers February 20240
Book Review: “Analytical Testing for the Pharmaceutical GMP Laboratory”0
Preparation and Characterization of ZGDHu-1 Nanoparticles0
In Vitro Bioequivalence of Acetylsalicylic Acid and Implications in Public Health0
Comparative Dissolution Study of Various Brands of Valsartan Tablets Marketed in Pakistan0
Comparison of Rosuvastatin Calcium Tablets Marketed in Saudi Arabia Under Biowaiver Conditions: In Vitro Quality Control Dissolution Study0
Questions and Answers February 20220
Comparison of In Vitro Phosphate-Binding Studies of Sevelamer Carbonate Using Incubator Shaker and USP Dissolution Apparatus II0
Preparation and Characterization of a Novel Optimum Modified Liquisolid Compact to Enhance the Dissolution Profile of Mifepristone0
The Importance of Dissolution Tests to Evaluate Quality of Dietary Supplements: Case Study of Controlled Release Caffeine Capsules0
Factors Influencing the Selection of Medium for Evaluating Drug Solubility and Dissolution in Bovine Milk0
Questions and Answers May 20230
Advances in Product Quality and Performance Tests for Topical and Transdermal Products: View of the USP Expert Panel0
Questions and Answers November 20210
Improved Melatonin Dissolution Properties: A Way Forward for Treating Children with Sleep Disorders0
Dissolution Method Troubleshooting: An Industry Perspective0
Dissolution Performance of Verapamil-HCl Tablets Using USP Apparatus 2 and 4: Prediction of In Vivo Plasma Profiles0
Comparative Assessment of Critical Quality Attributes of Sildenafil Tablets0
Overview of the Activities of the USP Expert Panel on New Advancements in Product Performance Testing0
Questions and Answers February 20230
Evaluation of In Vitro Equivalence of Commonly Available Generic Brands of Amlodipine Tablets in Saudi Arabia Under Biowaiver Conditions0
Dissolution Profile of Apixaban Tablets: Method Development and Validation Using HPLC Analysis0
Questions and Answers August 20210
Dissolution Specifications for Ibuprofen Soft Gelatin Capsules: A Proposal0
Questions and Answers November 20220
Review: Application of Bioequivalence Testing of Medicines in Peru0
Pharmaceutical Equivalence of Losartan Potassium Tablets in Argentina0
Therapeutic Equivalence Evaluated Through In Vitro Studies of Multi-Source Drugs: A Moxifloxacin Case Study in Lima, Peru0
Release Profile of Branded Atorvastatin Calcium Tablet Relative to Commercially Available Counterpart Generics0
Evaluation of a pH-Gradient Biphasic Dissolution Test for Predicting In Vivo Performance of Weakly Basic Drugs0
In Vitro Characterization of Multi-Source Omeprazole Capsule Dissolution Performance Under Biorelevant Conditions0
Questions and Answers August 20220
Testing the In Vitro Product Performance of Mucosal Drug Products: View of the USP Expert Panel0
Therapeutic Equivalence of Multisource Drugs Assessed by In Vitro Dissolution Studies: Amoxicillin/Clavulanic Acid Tablets0
Biorelevant Dissolution Testing of Numerically Optimized Multiparticulate Drug Delivery Systems of Gliclazide0
Comparative Study of Brand and Generics Ciprofloxacin Tablets Available in the Saudi Market0
Evaluation of Critical Quality Attributes of Dapsone Gel0
Influence of Different Concentrations of Surfactants on Dissolution Profiles of Extemporaneously Compounded Pessaries with Clindamycin Phosphate0
Comparative Evaluation of Amlodipine Besylate Generic Tablet and Capsule Brands in Riyadh, Saudi Arabia0
0.018563985824585